Reaction Details |
| Report a problem with these data |
Target | Gamma-aminobutyric acid receptor subunit alpha-1 |
---|
Ligand | BDBM513240 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Electrophysiology |
---|
Ki | 0.400±n/a nM |
---|
Citation | Buettelmann, B; Cecere, G; Fasching, B; Groebke Zbinden, K; Hernandez, M; Knust, H; Koblet, A; Pinard, E; Thomas, A Isoxazolyl ether derivatives as GABAA α5 PAM US Patent US11091471 Publication Date 8/17/2021 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Gamma-aminobutyric acid receptor subunit alpha-1 |
---|
Name: | Gamma-aminobutyric acid receptor subunit alpha-1 |
Synonyms: | Benzodiazepine central | GABA A Benzodiazepine brain | GABA A Benzodiazepine liver | GABA receptor alpha-1 subunit | GABA(A) receptor subunit alpha-1 | GABA-A | GABA-A receptor | GABRA1 | GBRA1_HUMAN | Gamma-aminobutyric acid receptor subunit alpha (GABAA) | TBPS | agonist GABA site |
Type: | Protein |
Mol. Mass.: | 51817.35 |
Organism: | Homo sapiens (Human) |
Description: | P14867 |
Residue: | 456 |
Sequence: | MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLLDGYDNRLRPG
LGERVTEVKTDIFVTSFGPVSDHDMEYTIDVFFRQSWKDERLKFKGPMTVLRLNNLMASK
IWTPDTFFHNGKKSVAHNMTMPNKLLRITEDGTLLYTMRLTVRAECPMHLEDFPMDAHAC
PLKFGSYAYTRAEVVYEWTREPARSVVVAEDGSRLNQYDLLGQTVDSGIVQSSTGEYVVM
TTHFHLKRKIGYFVIQTYLPCIMTVILSQVSFWLNRESVPARTVFGVTTVLTMTTLSISA
RNSLPKVAYATAMDWFIAVCYAFVFSALIEFATVNYFTKRGYAWDGKSVVPEKPKKVKDP
LIKKNNTYAPTATSYTPNLARGDPGLATIAKSATIEPKEVKPETKPPEPKKTFNSVSKID
RLSRIAFPLLFGIFNLVYWATYLNREPQLKAPTPHQ
|
|
|
BDBM513240 |
---|
n/a |
---|
Name | BDBM513240 |
Synonyms: | 6-((5-methyl-3-(6-methylpyridazin-3-yl)isoxazol-4-yl)methoxy)-N-tetrahydropyran-4-yl-pyridine-3-carboxamide | US11091471, Example 108 |
Type | Small organic molecule |
Emp. Form. | C21H23N5O4 |
Mol. Mass. | 409.4384 |
SMILES | Cc1onc(c1COc1ccc(cn1)C(=O)NC1CCOCC1)-c1ccc(C)nn1 |
Structure |
|